StockMarketWire.com - Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC [LON:HIK] and raised its price target to 2350p (from 2200p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk